Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
Beutler
E
E
Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, CA, USA.
Sipe
J
J
Romine
J
J
McMillan
R
R
Zyroff
J
J
Koziol
J
J
D000704:Analysis of Variance; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000473:pathology; D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006403:Hematologic Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D009460:Neurologic Examination; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy
D007166:Immunosuppressive Agents; D017338:Cladribine